Tutukon Neo®

| TUTUKON NEO is produced as oral solution (250 ml).
Hydrolat obtained from the distillation of herbal ingredients, vial №1

ATC Code: G04BX50, Other urologicals including combinations
TUTUKON® is a special composition of medical herbs extracted with unique technology of steam distillation providing maximal extraction of herbal ingredients and formulation of BIOLOGICALLY ACTIVE COMPLEX that:
Stimulates excretion of renal and ureteral stones ≤ 1cm,
Provides metaphylaxis of urolithiasis, and•
Facilitates elimination of pathogens from urinal tract.
The unique extraction technology of steam distillation makes possible to reach synergism in pharmacologic action of every herbal compound:
Spergularia rubra – dissolves oxalates, phosphates and urates through contains flavonoid fractions, increases urine output;
Peumus boldus – has disinfectant, urine and choleretic properties, anti-inflammatory and antipyretic effects are due to inhibition of the biosynthesis of prostaglandins;
Cynodon dactylon – has antibacterial and antifungal properties, stimulates phagocytosis and is used as an anti-inflammatory agent.
Sideritis angustifolia – being a diuretic, anti-inflammatory and has a wide antibacterial effects due to contained flavonoids, oils and tannins;
Opuntia ficus indica – characterized by strong diuretic and spasmolytic activity;
Rosmarinus officinalis – along with active spasmolytic, diuretic, bacteriostatic and antioxidant effects, has also choleretic effect;
Melissa officinalis – has significant spasmolytic activity, bacteriostatic and fungistatic properties and, in addition, also has mild sedative effect on the central nervous system;
Enguisetum arvensis – has a pronounced diuretic effect;
In pre-clinical trials it was proved on histological and biochemical levels that the synergistic pharmacological effect of TUTUKON® includes: diuretic effect, anti-bacterial effect, anti-inflammatory effect, anti-oxidant effect, spasmolytic effect, as well as litholytic and lithokinetic effects.
Due to such synergistic pharmacological effect TUTUKON® demonstrated in clinical trials the following effects:
control inflammation (leukocyturia)
normalize salt metabolism and diuresis (crystalluria and diuresis volume)
control of pain and spasm in acute patients
physiological dissolving stones and effective elimination small ones
In general the application of TUTUKON® in patients with urolithiasis and UTI may help to reach some important therapeutic objectives:
eliminate the main reason of the stone formation – ureteral tract epithelium cells apoptosis (death) and infringement of salt metabolism in patients;
prevent a stone formation in patient who has just crystalluria, rid off calculi and prevent surgery in patients with small stones (up to 1 cm), rid of residual calculi and prevent infection complications and recurrence in patients after lithotripsy;
increase effectiveness of antibiotic therapy or substitute it UT infections;
simplify the treatment in all types of stones and in all types of infections;

TUTUKON® is indicated for adult and paediatric patients as follows:
Excessive formation of salts in the kidneys (urates, oxalates, phosphates, carbonates),
Prevention of recurrent stone formation after removal of stones,
Urinary tract infections: cystitis, urethritis, pyelonephritis,
Dysuric phenomenos (polaquiuria, stranguria, dysuria, nicturia, loss urinary pressure and urinary continence),
Spasm of urinary and biliary tract,
Spastic colitis,
Different types of intoxication (drugs, alcohol, drugs, food poisoning).




Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.